AU7730575A - Influenza vaccine - Google Patents

Influenza vaccine

Info

Publication number
AU7730575A
AU7730575A AU77305/75A AU7730575A AU7730575A AU 7730575 A AU7730575 A AU 7730575A AU 77305/75 A AU77305/75 A AU 77305/75A AU 7730575 A AU7730575 A AU 7730575A AU 7730575 A AU7730575 A AU 7730575A
Authority
AU
Australia
Prior art keywords
influenza vaccine
influenza
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU77305/75A
Other versions
AU500250B2 (en
Inventor
H. & Schmidt G Bachmayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7730575A publication Critical patent/AU7730575A/en
Application granted granted Critical
Publication of AU500250B2 publication Critical patent/AU500250B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU77305/75A 1974-01-14 1975-01-14 Influenza vaccine Expired AU500250B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14
GHGH447/74 1974-01-14

Publications (2)

Publication Number Publication Date
AU7730575A true AU7730575A (en) 1976-07-15
AU500250B2 AU500250B2 (en) 1979-05-17

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77305/75A Expired AU500250B2 (en) 1974-01-14 1975-01-14 Influenza vaccine

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU585353B2 (en) * 1985-06-06 1989-06-15 Daiichi Pharmaceutical Co., Ltd. Influenza vaccine

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
NZ567817A (en) * 2005-11-01 2012-01-12 Novartis Vaccines & Diagnostic Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
AU2008293513B2 (en) * 2007-08-28 2013-11-21 Nanotherapeutics, Inc. Method for producing viral vaccines
EP3068791B1 (en) 2013-11-15 2020-07-29 Novartis AG Removal of residual cell culture impurities

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU585353B2 (en) * 1985-06-06 1989-06-15 Daiichi Pharmaceutical Co., Ltd. Influenza vaccine

Also Published As

Publication number Publication date
SE427238B (en) 1983-03-21
DK140003B (en) 1979-06-05
FR2257305A1 (en) 1975-08-08
YU41289B (en) 1987-02-28
HK56380A (en) 1980-10-16
JPS58407B2 (en) 1983-01-06
NL166622C (en) 1981-09-15
FR2257305B1 (en) 1982-03-19
ES433759A1 (en) 1977-02-16
NO143128B (en) 1980-09-15
BE824372A (en) 1975-07-14
CS191254B2 (en) 1979-06-29
MY8100204A (en) 1981-12-31
YU5875A (en) 1984-04-30
DE2500785A1 (en) 1975-07-31
HU173920B (en) 1979-09-28
GB1498261A (en) 1978-01-18
DK140003C (en) 1979-10-29
PH14458A (en) 1981-07-29
FI750014A (en) 1975-07-15
DE2500785B2 (en) 1980-01-03
SU616997A3 (en) 1978-07-25
FI54053C (en) 1978-10-10
NL166622B (en) 1981-04-15
SE7500130L (en) 1975-07-15
DD116239A5 (en) 1975-11-12
JPS56127319A (en) 1981-10-06
PL93689B1 (en) 1977-06-30
NO750031L (en) 1975-08-11
IL46426A (en) 1978-01-31
DE2500785C3 (en) 1980-09-11
JPS6035326B2 (en) 1985-08-14
CH589453A5 (en) 1977-07-15
AT345449B (en) 1978-09-11
AU500250B2 (en) 1979-05-17
IL46426A0 (en) 1975-04-25
NO143128C (en) 1980-12-29
ZA75259B (en) 1976-08-25
IE40794B1 (en) 1979-08-15
IE40794L (en) 1975-07-14
DK1475A (en) 1975-09-01
FI54053B (en) 1978-06-30
CA1049406A (en) 1979-02-27
NL7500301A (en) 1975-07-16
ATA21475A (en) 1978-01-15
JPS50100224A (en) 1975-08-08

Similar Documents

Publication Publication Date Title
CA1027416A (en) Wingfold configuration
AU497398B2 (en) Tetanus vaccine
AU467292B2 (en) Eye-bush
AU500250B2 (en) Influenza vaccine
CA1034136A (en) O-aminosulfonyglycolic anilides
AU498810B2 (en) Influenza vaccines
AU503647B2 (en) Antipregnancy vaccine
SU565112A1 (en) Moment hydrocylinder
AU497239B2 (en) Parainfluenza virus vaccine
AU494738B2 (en) Virus subunit vaccine
AU485538B2 (en) Preparation ofa-6-deoxy-5-hydroxytetracycline
AU490363B2 (en) Scaffolding
AU480112B2 (en) Wingfold configuration
AU489628B2 (en) Cinnoline derivatives
AU494543B2 (en) Pharmaceutical formulations
AU486500B2 (en) Xeroradiographic member
AU8054075A (en) Preparation ofa-6-deoxy-5-hydroxytetracycline
AU475114B2 (en) Arylalkylsulphoxides
AU482524B2 (en) Pyridoindoles
AU468625B2 (en) Wire-connector
AU488720B2 (en) 2-deutero-3-fluoro-alanine
AU488592B2 (en) Tapemeasure
AU488320B2 (en) Polycycloanilines
AU483104B2 (en) Dipenylpropylamines
AU463759B2 (en) Cyclopentanediones